These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

624 related articles for article (PubMed ID: 29373651)

  • 1. Extracellular matrix glycation and receptor for advanced glycation end-products activation: a missing piece in the puzzle of the association between diabetes and cancer.
    Rojas A; Añazco C; González I; Araya P
    Carcinogenesis; 2018 Apr; 39(4):515-521. PubMed ID: 29373651
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stimulatory effects of advanced glycation endproducts (AGEs) on fibronectin matrix assembly.
    Pastino AK; Greco TM; Mathias RA; Cristea IM; Schwarzbauer JE
    Matrix Biol; 2017 May; 59():39-53. PubMed ID: 27425255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of CCN2 and Its Bioactivity by Advanced Glycation End Products.
    Wang X; Min D; Twigg SM
    Methods Mol Biol; 2023; 2582():355-367. PubMed ID: 36370363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extracellular matrix components isolated from diabetic mice alter cardiac fibroblast function through the AGE/RAGE signaling cascade.
    Burr SD; Stewart JA
    Life Sci; 2020 Jun; 250():117569. PubMed ID: 32201277
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implication of advanced glycation end products (Ages) and their receptor (Rage) on myocardial contractile and mitochondrial functions.
    Neviere R; Yu Y; Wang L; Tessier F; Boulanger E
    Glycoconj J; 2016 Aug; 33(4):607-17. PubMed ID: 27277623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advanced glycation end products (AGEs) and cardiovascular dysfunction: focus on high molecular weight AGEs.
    Deluyker D; Evens L; Bito V
    Amino Acids; 2017 Sep; 49(9):1535-1541. PubMed ID: 28710551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting extracellular matrix glycation to attenuate fibroblast activation.
    Jang M; Oh SW; Lee Y; Kim JY; Ji ES; Kim P
    Acta Biomater; 2022 Mar; 141():255-263. PubMed ID: 35081431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advanced Glycation End Products, Diabetes, and Bone Strength.
    Yamamoto M; Sugimoto T
    Curr Osteoporos Rep; 2016 Dec; 14(6):320-326. PubMed ID: 27704396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glycative stress from advanced glycation end products (AGEs) and dicarbonyls: An emerging biological factor in cancer onset and progression.
    Lin JA; Wu CH; Lu CC; Hsia SM; Yen GC
    Mol Nutr Food Res; 2016 Aug; 60(8):1850-64. PubMed ID: 26774083
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathological Role of Advanced Glycation End Products (AGEs) and their Receptor Axis in Atrial Fibrillation.
    Yamagishi SI; Sotokawauchi A; Matsui T
    Mini Rev Med Chem; 2019; 19(13):1040-1048. PubMed ID: 30854960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advanced glycation end products and their receptor in age-related, non-communicable chronic inflammatory diseases; Overview of clinical evidence and potential contributions to disease.
    Reynaert NL; Gopal P; Rutten EPA; Wouters EFM; Schalkwijk CG
    Int J Biochem Cell Biol; 2016 Dec; 81(Pt B):403-418. PubMed ID: 27373680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advanced glycation end products: a link between periodontitis and diabetes mellitus?
    Gurav AN
    Curr Diabetes Rev; 2013 Sep; 9(5):355-61. PubMed ID: 23845077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advanced glycation end-products regulate extracellular matrix-adipocyte metabolic crosstalk in diabetes.
    Strieder-Barboza C; Baker NA; Flesher CG; Karmakar M; Neeley CK; Polsinelli D; Dimick JB; Finks JF; Ghaferi AA; Varban OA; Lumeng CN; O'Rourke RW
    Sci Rep; 2019 Dec; 9(1):19748. PubMed ID: 31875018
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of the receptor for advanced glycation end products and consequences on health.
    Wautier MP; Guillausseau PJ; Wautier JL
    Diabetes Metab Syndr; 2017; 11(4):305-309. PubMed ID: 27612394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glycated collagen - a 3D matrix system to study pathological cell behavior.
    Dandia H; Makkad K; Tayalia P
    Biomater Sci; 2019 Aug; 7(8):3480-3488. PubMed ID: 31282511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of Advanced Glycation End Products in Carcinogenesis and their Therapeutic Implications.
    Schröter D; Höhn A
    Curr Pharm Des; 2018; 24(44):5245-5251. PubMed ID: 30706806
    [TBL] [Abstract][Full Text] [Related]  

  • 17. AGEs, RAGEs and s-RAGE; friend or foe for cancer.
    Ahmad S; Khan H; Siddiqui Z; Khan MY; Rehman S; Shahab U; Godovikova T; Silnikov V; Moinuddin
    Semin Cancer Biol; 2018 Apr; 49():44-55. PubMed ID: 28712719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advanced Glycation End Products (AGEs), Glutathione and Breast Cancer: Factors, Mechanism and Therapeutic Interventions.
    Sharma AK; Sharma VR; Gupta GK; Ashraf GM; Kamal MA
    Curr Drug Metab; 2019; 20(1):65-71. PubMed ID: 30207227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Non-enzymatic glycation of proteins: from diabetes to cancer].
    Ansari NA; Rasheed Z
    Biomed Khim; 2010; 56(2):168-78. PubMed ID: 21341505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advanced glycation endproducts produced by in vitro glycation of type I collagen modulate the functional and secretory behavior of dorsal root ganglion cells cultivated in two-dimensional system.
    Bufalo MC; Almeida ME; Franca IA; Zambelli VO; Martins Sant'anna MB; Kimura LF; Giardini AC; Cury Y; Sampaio SC
    Exp Cell Res; 2019 Sep; 382(2):111475. PubMed ID: 31255600
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.